Skip to main content

Stem Cells for Cancer: Reprogrammed Cells & Cord Blood for Remission

Breakthrough stem cell approaches to cancer treatment. Reprogrammed HSCs, cord blood NK cell therapy for lymphoma, and next-generation immunotherapy for cancer remission.

MSC Therapy as Complementary Support — Not Cancer Treatment

StemCell Longevita positions MSC therapy strictly as supportive/complementary care for cancer patients — we do not claim to treat, cure, or remit cancer. The evidence supports MSC therapy for specific supportive indications: (1) Post-chemotherapy immune reconstitution — MSCs accelerate bone marrow recovery and normalise immune cell populations after cytotoxic chemotherapy; (2) Graft-versus-host disease (GvHD) prevention and treatment — allogeneic MSCs are the most evidence-supported therapy for steroid-refractory GvHD (multiple published RCTs, regulatory submissions); (3) Radiation/chemotherapy-induced tissue damage repair — MSCs promote healing of irradiated tissues (mucositis, radiation enteritis, pulmonary fibrosis).

Important Safety Considerations for Cancer Patients

MSC therapy is not appropriate for patients with active, uncontrolled malignancy. The immunosuppressive properties of MSCs, while therapeutically valuable for autoimmune conditions, could theoretically create an immunological environment that is less hostile to tumour cells in an active cancer setting. All cancer history patients receive individual evaluation by our medical team, and treatment is only considered for patients in confirmed remission (minimum 2 years for most solid tumours) or for the specific GvHD/supportive care indications where evidence supports safe use.

Post-Remission Supportive Programme

For cancer survivors in confirmed remission seeking immune restoration, fatigue management, and tissue repair after cytotoxic treatment, our post-oncology supportive programme delivers 2–3 IV MSC infusion sessions combined with exosome therapy. Pre-treatment oncology clearance and current tumour marker review are mandatory. The programme focuses on quality-of-life restoration rather than any cancer treatment claim.

Frequently Asked Questions

How do stem cells treat autoimmune diseases?
MSCs have powerful immunomodulatory properties that help rebalance an overactive immune system. They suppress autoreactive T-cells, promote regulatory T-cells, reduce pro-inflammatory cytokines, and support tissue repair damaged by autoimmune attack.
Which autoimmune diseases can be treated with stem cells?
We treat lupus, rheumatoid arthritis, multiple sclerosis, Crohn's disease, ulcerative colitis, psoriasis, scleroderma, and other autoimmune conditions. Each protocol is tailored to the specific disease mechanism.
How effective is stem cell therapy for autoimmune conditions?
Clinical studies show significant improvements in disease activity scores, reduced flare frequency, lower inflammatory markers, and decreased medication requirements. Many patients experience meaningful symptom relief within 1-3 months.
Can stem cell therapy replace immunosuppressive medications?
While MSC therapy can help reduce the need for immunosuppressive drugs in many patients, medication changes should always be made under medical supervision. Our team works with your home physician to optimize your treatment plan.

Related articles: Understanding Stem Cell Therapy (2026 Complete Guide) | Cord Blood vs. Bone Marrow Stem Cells: Which Is Better for Treatment? | Types of Stem Cells Explained (2026 Update)

Related treatments: Autoimmune Disease Stem Cell Therapy | Anti-Aging Stem Cell Therapy | Cardiovascular Stem Cell Treatment

Happy family benefiting from stem cell therapy
International Regenerative Medicine Center

Transform Your Health with Regenerative Medicine in Istanbul

Experience the future of medicine at StemCell Longevita. Our licensed medical professionals use physician-directed regenerative medicine applications to help you pursue optimal health and longevity.

Book Free Consultation Learn More
4,850+
Patients
14+
Years
98%
Satisfaction
52+
Countries